IP Library Granted Patent US 9,079,890
Granted Patent B2
US 9,079,890 · App. 14/494,430 · Granted Jul 14, 2015

Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives

Inventors: Thomas Daniel Aicher (Ann Arbor, MI); Steven Armen Boyd (Mars, PA); Mark Joseph Chicarelli (Boulder, CO); Kevin Ronald Condroski (San Diego, CA); Jay Bradford Fell (Boulder, CO); John P. Fischer (Boulder, CO); Indrani W. Gunawardana (Boulder, CO); Ronald Jay Hinklin (Boulder, CO); Ajay Singh (Broomfield, CO); Timothy M. Turner (Longmont, CO); Eli M. Wallace (Richardson, TX)
Assignee: Array BioPharma Inc.
C07D401/14C07D213/75C07D401/12C07D417/12C07D417/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,079,890
App. No.
14/494,430
Granted
Jul 14, 2015
Kind
B2
Abstract

Provided are intermediates having the formulas wherein R 2 , R 3 , and L are as defined in the specification, which are useful in the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives.

Claims (69)

1. A compound of formula:

where:

L is O or S;

R 2 is Ar 1 , hetAr 1 , hetAr 2 or hetAr 3 ;

Ar 1 is phenyl or naphthyl, each of which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, CF 3 , OH, CN, SO 2 Me, C(═O)NH(1-3C alkyl)N(alkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 1 ;

hetAr 1 is a 5-6 membered heteroaryl group having 1-3 ring nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C alkyl), Cl, CF 3 and (1-6C alkyl)OH;

hetAr 2 is a partially unsaturated 5,6 or 6,6 bicyclic heteroaryl ring system having 1-2 ring nitrogen atoms and optionally having a ring oxygen atom;

hetAr 3 is a 9-10 membered bicyclic heteroaryl ring having 1-3 ring nitrogen atoms;

R 3 is Cl, Br, CF 3 , aryl, hetAr a , SR 6 or OR 6 ;

hetAr 1 is a 6-membered heteroaryl having 1-2 ring nitrogen atoms;

R 6 is Ar 2 , hetAr 4 , (1-6C alkyl), -(1-6C alkyl)OH, polyhydroxy(1-6C alkyl), —CH(R 9 )—Ar 3 , —CH(R 19 )-hetAr 5 , hetAr 6 , (5-6C)cycloalkyl substituted with 1 to 4 OH, (1-3 C alkoxy)(1-6C alkyl), or cyclopropyl(1-6C alkyl);

Ar 2 is phenyl optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3 Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 ;

hetAr 4 is a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3 Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 ;

Ar 3 is phenyl optionally substituted with one or more groups independently selected from F, Cl, Br, and (1-6C)alkyl;

hetAr 5 is a 5-6-membered heteroaryl having 1-2 ring nitrogen atoms;

hetAr 6 is a 9-10 membered bicyclic heteroaromatic ring having 2-3 heteroatoms independently selected from N, S and O (provided the ring does not contain an O—O bond) which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, —O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl) and C(═O)NH(1-3C alkyl)N(1-3 Calkyl) 2 ;

R 9 and R 10 are independently hydrogen, (1-6C)alkyl, (1-6C)alkylOH, or CF 3 ; and

hetCyc 1 and hetCyc 2 are independently a 5-7 membered heterocyclic ring having 1-2 ring heteroatoms independently selected from N and O;

provided that the compound is not:

1-(5-chloro-3-phenoxypyridin-2-yl)thiourea,

1-(5-bromo-3-phenoxypyridin-2-yl)thiourea,

1-(5-bromo-3-(4-fluorophenoxy)pyridin-2-yl)thiourea,

1-(5-bromo-3-(phenylthio)pyridin-2-yl)thiourea,

1-(5-bromo-3-(4-cyanophenoxyl)pyridin-2-yl)thiourea, or

1-(3-(2-bromo-4-fluorophenoxy)-5-(3-methoxyphenylthio)pyridin-2-yl)thiourea.

2. The compound of claim 1 where L is O.

3. The compound of claim 1 where R 2 is

4. The compound of claim 1 , where:

R 3 is SR 6 ; and

R 6 is Ar 2 , hetAr 4 , -(1-6C alkyl), -(1-6C alkyl)OH, polyhydroxy(1-6C alkyl), —CH(R 9 )—Ar 3 , —CH(R 10 )-hetAr 5 , hetAr 6 , (5-6C)cycloalkyl substituted with 1 to 4 OH, (1-3C alkoxy)(1-6C alkyl), or cyclopropyl(1-6C alkyl).

5. The compound of claim 1 , where:

R 3 is SR 6 ;

R 6 is hetAr 4 ; and

hetAr 4 is a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 .

6. The compound of claim 1 , where R 3 is

7. A compound of formula:

where:

L is O or S;

R 2 is Ar 1 , hetAr 1 , hetAr 2 or hetAr 3 ;

Ar 1 is phenyl or naphthyl, each of which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, CF 3 , OH, CN, SO 2 Me, C(═O)NH(1-3C alkyl)N(alkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 1 ;

hetAr 1 is a 5-6 membered heteroaryl group having 1-3 ring nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C alkyl), Cl, CF 3 and (1-6C alkyl)OH;

hetAr 2 is a partially unsaturated 5,6 or 6,6 bicyclic heteroaryl ring system having 1-2 ring nitrogen atoms and optionally having a ring oxygen atom;

hetAr 3 is a 9-10 membered bicyclic heteroaryl ring having 1-3 ring nitrogen atoms;

R 3 is Cl, Br, CF 3 , aryl, hetAr a , SR 6 or OR 6 ;

hetAr a is a 6-membered heteroaryl having 1-2 ring nitrogen atoms;

R 6 is Ar 2 , hetAr 4 , (1-6C alkyl), -(1-6C alkyl)OH, polyhydroxy(1-6C alkyl), —CH(R 9 )—Ar 3 , —CH(R 10 )-hetAr 5 , hetAr 6 , (5-6C)cycloalkyl substituted with 1 to 4 OH, (1-3C alkoxy)(1-6C alkyl), or cyclopropyl(1-6C alkyl);

Ar 2 is phenyl optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 ;

hetAr 4 is a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3 Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 ;

Ar 3 is phenyl optionally substituted with one or more groups independently selected from F, Cl, Br, and (1-6C)alkyl;

hetAr 5 is a 5-6-membered heteroaryl having 1-2 ring nitrogen atoms;

hetAr 6 is a 9-10 membered bicyclic heteroaromatic ring having 2-3 heteroatoms independently selected from N, S and O (provided the ring does not contain an O—O bond) which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, —O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl) and C(═O)NH(1-3C alkyl)N(1-3Calkyl) 2 ;

R 9 and R 10 are independently hydrogen, (1-6C)alkyl, (1-6C)alkylOH, or CF 3 ; and

hetCyc 1 and hetCyc 2 are independently a 5-7 membered heterocyclic ring having 1-2 ring heteroatoms independently selected from N and O;

provided that the compound is not

5-chloro-3-phenoxypyridin-2-amine,

5-bromo-3-(4-fluorophenoxyl)pyridin-2-amine,

5-Bromo-3-(phenylthio)pyridin-2-amine,

3-(2-bromo-4-fluorophenoxy)-5-(3-methoxyphenylthio)pyridin-2-amine, or

5-bromo-3-phenoxypyridin-2-amine.

8. The compound of claim 7 where L is O.

9. The compound of claim 7 where R 2 is

10. The compound of claim 7 , where:

R 3 is SR 6 ; and

R 6 is Ar e , hetAr 4 , (1-6C alkyl), -(1-6C alkyl)OH, polyhydroxy(1-6C alkyl), —CH(R 9 )—Ar 3 , —CH(R 10 -hetAr 5 , hetAr 6 , (5-6C)cycloalkyl substituted with 1 to 4 OH, (1-3C alkoxy)(1-6C alkyl), or cyclopropyl(1-6C alkyl).

11. The compound of claim 7 , where:

R 3 is SR 6 ;

R 6 is hetAr 4 ; and

hetAr 4 is a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF 3 , CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3 Calkyl) 2 and C(═O)NH(1-3C alkyl)hetCyc 2 .

12. The compound of claim 7 , where R 3 is

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2015
From: AICHER, THOMAS DANIEL; BOYD, STEVEN ARMEN; CHICARELLI, MARK JOSEPH; CONDROSKI, KEVIN RONALD; FELL, JAY BRADFORD; FISCHER, JOHN P.; GUNAWARDANA, INDRANI W.; HINKLIN, RONALD JAY; SINGH, AJAY; TURNER, TIMOTHY M.; WALLACE, ELI M.
To: ARRAY BIOPHARMA, INC.
Reel/Frame 035268/0001 →
Continuity (4)
Continuation 13493616 · Jun 11, 2012
Continuation 12678995
Provisional Application 60974225 · Sep 21, 2007
Related Publication 20150057448A1 · Feb 26, 2015